The three common isoforms of human apolipoprotein (apo) E (apoE2, apoE3, and apoE4) have remarkably different influences on plasma lipoprotein metabolism and Alzheimer's disease (AD). Genetic evidence clearly establishes that the apoE4 allele is a major risk factor for AD and that, in some populations, the apoE2 allele appears to be protective. The long-range objective of our research is to understand the role of apoE in the etiology of AD and the basis for different effects that the three isoforms have on the disease. A fundamental requirement to achieve this objective and a major focus of this proposal is to determine the basic physical-biochemical properties and structure-function relationships of the three apoE isoforms. The foundation of this proposal is based on our hypothesis that the properties and characteristics of apoE4 directly result from the interaction of the two structural domains in the protein, a phenomenon referred to as apoE4 domain interaction. The research plan is organized into three specific aims.
Specific Aim l will compare the physical-biochemical properties of apoE4, apoE2, and the apoE3 homo-dimer with those of apoE3 and improve the three-dimensional structural models of apoE2, apoE3, and apoE4.
Specific Aim 2 will define apoE4 domain interaction using a combination of deletion mutagenesis and x-ray crystallography. Also, a disulfide-linked model of domain interaction will be produced.
Specific Aim 3 will examine the interaction of various forms of lipid-free and lipid-associated apoE with the l-28 and 1-40 Abeta peptides. These studies will provide a critical and necessary foundation for the eventual understanding of the structure-function relationships of the apoE isoforms in AD.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Project (R01)
Project #
Application #
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Program Officer
Oliver, Eugene J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
J. David Gladstone Institutes
San Francisco
United States
Zip Code
Zhong, Ning; Scearce-Levie, Kimberly; Ramaswamy, Gayathri et al. (2008) Apolipoprotein E4 domain interaction: synaptic and cognitive deficits in mice. Alzheimers Dement 4:179-92
Acharya, Prathima; Segall, Mark L; Zaiou, Mohamed et al. (2002) Comparison of the stabilities and unfolding pathways of human apolipoprotein E isoforms by differential scanning calorimetry and circular dichroism. Biochim Biophys Acta 1584:9-19
Morrow, Julie A; Hatters, Danny M; Lu, Bin et al. (2002) Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease. J Biol Chem 277:50380-5
Dong, J; Peters-Libeu, C A; Weisgraber, K H et al. (2001) Interaction of the N-terminal domain of apolipoprotein E4 with heparin. Biochemistry 40:2826-34
Raffai, R L; Dong, L M; Farese Jr, R V et al. (2001) Introduction of human apolipoprotein E4 ""domain interaction"" into mouse apolipoprotein E. Proc Natl Acad Sci U S A 98:11587-91
Morrow, J A; Segall, M L; Lund-Katz, S et al. (2000) Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain. Biochemistry 39:11657-66
Segelke, B W; Forstner, M; Knapp, M et al. (2000) Conformational flexibility in the apolipoprotein E amino-terminal domain structure determined from three new crystal forms: implications for lipid binding. Protein Sci 9:886-97
Morrow, J A; Arnold, K S; Weisgraber, K H (1999) Functional characterization of apolipoprotein E isoforms overexpressed in Escherichia coli. Protein Expr Purif 16:224-30